Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura C Coates

Showing results (131-140 of 342) with videos related to

Pageof 35
Sort By:
Rheumatology (Oxford, England)|January 13, 2017
New GRAPPA and EULAR recommendations for the management of psoriatic arthritisLaura C Coates, Laure Gossec, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|October 22, 2024
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOSLaure Gossec, Xenofon Baraliakos, Daniel Aletaha, et al.
Clinical Rheumatology|June 8, 2022
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year resultsLaura C Coates, Philip Mease, Andris Kronbergs, et al.
Rheumatology and Therapy|March 17, 2022
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient SurveyPascal Richette, Laura C Coates, Valderilio F Azevedo, et al.
The Journal of Rheumatology|October 15, 2022
Sex-Specific Differences in Patients With Psoriatic Arthritis: A Systematic ReviewLaura C Coates, Irene E van der Horst-Bruinsma, Ennio Lubrano, et al.
Rheumatology and Therapy|June 11, 2017
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and PatientsMarco Garrido-Cumbrera, Ottfrid Hillmann, Raj Mahapatra, et al.
Frontiers in Medicine|September 22, 2018
Classification and Outcome Measures for Psoriatic ArthritisYing Ying Leung, Alexis Ogdie, Ana-Maria Orbai, et al.
The Lancet. Rheumatology|January 17, 2024
Precision medicine in psoriatic arthritis: how should we select targeted therapies?Hussein Al-Mossawi, Leonie S Taams, Carl S Goodyear, et al.
Annals of the Rheumatic Diseases|July 28, 2017
GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studiesWilliam Tillett, Ana-Maria Orbai, Alexis Ogdie, et al.
Annals of the Rheumatic Diseases|July 24, 2019
Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves <i>et al</i>Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, et al.
Pageof 35

Showing results (131-140 of 342) with videos related to

Sort By:
Pageof 35
Rheumatology (Oxford, England)|January 13, 2017
New GRAPPA and EULAR recommendations for the management of psoriatic arthritisLaura C Coates, Laure Gossec, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|October 22, 2024
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOSLaure Gossec, Xenofon Baraliakos, Daniel Aletaha, et al.
Clinical Rheumatology|June 8, 2022
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year resultsLaura C Coates, Philip Mease, Andris Kronbergs, et al.
Rheumatology and Therapy|March 17, 2022
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient SurveyPascal Richette, Laura C Coates, Valderilio F Azevedo, et al.
The Journal of Rheumatology|October 15, 2022
Sex-Specific Differences in Patients With Psoriatic Arthritis: A Systematic ReviewLaura C Coates, Irene E van der Horst-Bruinsma, Ennio Lubrano, et al.
Rheumatology and Therapy|June 11, 2017
Improving the Management of Psoriatic Arthritis and Axial Spondyloarthritis: Roundtable Discussions with Healthcare Professionals and PatientsMarco Garrido-Cumbrera, Ottfrid Hillmann, Raj Mahapatra, et al.
Frontiers in Medicine|September 22, 2018
Classification and Outcome Measures for Psoriatic ArthritisYing Ying Leung, Alexis Ogdie, Ana-Maria Orbai, et al.
The Lancet. Rheumatology|January 17, 2024
Precision medicine in psoriatic arthritis: how should we select targeted therapies?Hussein Al-Mossawi, Leonie S Taams, Carl S Goodyear, et al.
Annals of the Rheumatic Diseases|July 28, 2017
GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studiesWilliam Tillett, Ana-Maria Orbai, Alexis Ogdie, et al.
Annals of the Rheumatic Diseases|July 24, 2019
Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves <i>et al</i>Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, et al.
Pageof 35